PACB – Pacific Biosciences of California, Inc.

Pacific Biosciences of Californ

PACB

$1.45

Name : Pacific Biosciences of Californ

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $437,897,568.00

EPSttm : -1.82

Pacific Biosciences of Californ

$1.45

8.21%

$0.11

PACB — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

16.82

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

EPS Last/This Y

1.31

EPS This/Next Y

0.09

Price

1.46

Target Price

2.36

Analyst Recom

2.33

Performance Q

-25.26

Upside

-2,876.6%

Beta

2.39

Ticker: PACB

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	PACB	1.38	0.15	0.62	78213
2026-03-18	PACB	1.325	0.15	0.31	78321
2026-03-19	PACB	1.405	0.15	0.99	78425
2026-03-20	PACB	1.325	0.15	0.03	78682
2026-03-23	PACB	1.385	0.20	0.01	51310
2026-03-24	PACB	1.385	0.19	0.00	52550
2026-03-25	PACB	1.395	0.19	1.24	53106
2026-03-26	PACB	1.345	0.19	0.55	53193
2026-03-27	PACB	1.255	0.20	0.30	53191
2026-03-30	PACB	1.255	0.19	0.15	53771
2026-03-31	PACB	1.315	0.19	0.26	53813
2026-04-01	PACB	1.34	0.19	0.02	53974
2026-04-02	PACB	1.345	0.19	0.43	54668
2026-04-06	PACB	1.41	0.19	0.09	54740
2026-04-08	PACB	1.465	0.19	0.95	55351
2026-04-09	PACB	1.355	0.19	0.24	55494
2026-04-13	PACB	1.46	0.18	0.10	60171
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	PACB	1.38	11.8	382.1	-0.50
2026-03-18	PACB	1.33	11.8	386.1	-0.50
2026-03-19	PACB	1.40	11.8	367.5	-0.50
2026-03-20	PACB	1.33	11.8	376.3	-0.50
2026-03-23	PACB	1.38	11.8	368.4	-0.50
2026-03-24	PACB	1.38	11.8	372.3	-0.50
2026-03-25	PACB	1.40	11.8	371.5	-0.50
2026-03-26	PACB	1.34	11.8	375.1	-0.50
2026-03-27	PACB	1.26	11.8	377.2	-0.50
2026-03-30	PACB	1.25	11.8	372.3	-0.50
2026-03-31	PACB	1.31	11.8	369.0	-0.50
2026-04-01	PACB	1.34	11.8	370.9	-0.50
2026-04-02	PACB	1.34	11.8	372.7	-0.50
2026-04-06	PACB	1.42	12.5	367.9	-0.51
2026-04-07	PACB	1.44	12.5	371.6	-0.51
2026-04-09	PACB	1.35	12.5	379.1	-0.51
2026-04-10	PACB	1.35	12.5	372.7	-0.51
2026-04-13	PACB	1.46	12.5	364.8	-0.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	PACB	-2.32	5.87	14.08
2026-03-18	PACB	-2.32	5.87	14.08
2026-03-19	PACB	-2.32	5.87	14.08
2026-03-20	PACB	-2.32	5.87	14.08
2026-03-23	PACB	-2.32	5.80	14.08
2026-03-24	PACB	-2.32	5.80	14.08
2026-03-25	PACB	-2.32	5.80	15.26
2026-03-26	PACB	-2.32	5.80	15.26
2026-03-27	PACB	-2.32	5.80	15.26
2026-03-30	PACB	-2.32	5.80	15.26
2026-03-31	PACB	-2.32	5.80	15.26
2026-04-01	PACB	-2.32	5.80	15.26
2026-04-02	PACB	-2.32	5.80	15.26
2026-04-06	PACB	-2.59	5.79	15.26
2026-04-07	PACB	-2.59	5.79	15.26
2026-04-08	PACB	-2.59	5.79	15.26
2026-04-09	PACB	-2.59	5.79	15.26
2026-04-10	PACB	-2.59	5.79	15.26
2026-04-13	PACB	-2.59	5.81	16.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.12

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

-2.59

Institutional Transactions

5.81

Beta

2.39

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-97.5

Target Price

2.36

P/E

Forward P/E

PEG

P/S

2.74

P/B

81.87

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y

-0.51

EPS Next Y. (Est.)

-0.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-341.47

Relative Volume

0.7

Return on Equity vs Sector %

-10241.9

Return on Equity vs Industry %

-10226.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

364.8

◆ PACB Healthcare

$1.45

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

11/25

Volume

9/15

Valuation

12/20

TP/AR

3/10

Options

8/10

RSI

51.5

Range 1M

61.1%

Sup Dist

9.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

23/30

Estimates

3/20

Inst/Vol

6/15

Options

8/10

EPS Yr

71.6%

EPS NY

11.6%

52W%

31.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +62.8% upside

Quality

2/30

Valuation

14/30

Growth

17/25

Stability

4/10

LT Trend

0/5

Upside

+62.8%

Quality

Pacific Biosciences of Californ

Sector: Healthcare

Industry: Medical Devices

Employees: 485

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, and Sequel instruments which conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips; short-read sequencing; and onso instrument. It serves academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. It has a collaboration with DNAstack Inc. to provide federated dataset of HiFi whole genome sequencing data. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

PACB

Latest News

—

Caricamento notizie per PACB…

stock quote shares PACB – Pacific Biosciences of California, Inc. Stock Price stock today

news today PACB – Pacific Biosciences of California, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PACB – Pacific Biosciences of California, Inc. yahoo finance google finance

stock history PACB – Pacific Biosciences of California, Inc. invest stock market

stock prices PACB premarket after hours

ticker PACB fair value insiders trading

PACB – Pacific Biosciences of California, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PACB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y